News and Analysis

Bessemer Ventures leads Series A round for Rupa Health

Rupa Health, a digital healthcare platform, has raised $20 million in Series A funding.

-

Rupa Health, a digital healthcare platform, has raised $20 million in Series A funding. Bessemer Ventures led the round.

PRESS RELEASE

San Francisco, CA – March 1, 2022 – Rupa Health, a healthcare company that is building the digital platform for the next evolution of medicine, root cause medicine, today announced the close of a $20 million Series A led by Bessemer Ventures (Partners Talia Goldberg and Jeremy Levine). The total funding for Rupa is now at $26 million. Bessemer joins existing investors First Round Capital, Lachy Groom, SV Angel, Floodgate, Hustle Fund, Operator Collective, the Chainsmokers, Jared Leto, Joe Montana and more who all participated in the latest round as well.
Rupa is revolutionizing medicine by enabling access to root cause medicine – where practitioners aim to identify and solve the true, underlying cause of an illness. A root cause approach looks at a person’s health holistically and employs advanced, comprehensive diagnostics to understand everything from genetics to diet, stress and cortisol levels to the microbiome, and more.

Rupa solves the most difficult part about practicing root cause medicine: labwork. Traditional bloodwork — the complete blood counts (CBCs) and metabolic panels (CMPs) historically ordered — are not the full picture. To get to the root cause, practitioners rely on cutting edge tools like advanced DNA tests, microbiome tests, comprehensive hormone panels, heavy metals testing, nutrient profiles, and more. The foundation for practicing root cause medicine is in this “fact finding” about a patient’s health, primarily done through comprehensive lab work.

Rupa’s first product is a single sign-on lab ordering portal that gives doctors access to over 3,000 specialty lab tests in one place, turning 15 hours of weekly physician admin work into 15 minutes. Before Rupa, doctors had to sign up separately with 20+ independent lab companies. To order and receive results, they dealt with a nightmare of faxes, phone calls, logins, and snail mail.